Moses Goddard

Corporate Officer/Principal en Semma Therapeutics, Inc. .

Health Technology

Perfil

Moses Goddard is the founder of CytoSolv, Inc., a company founded in 2009.
He held the title of President, Secretary, Treasurer & Director at CytoSolv, Inc. Dr. Goddard is currently working as the Vice President-Surgery at Semma Therapeutics, Inc.

Cargos activos de Moses Goddard

Empresas	Cargo	Inicio
Semma Therapeutics, Inc. Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	18/12/2018

Todos los cargos activos de Moses Goddard

Antiguos cargos conocidos de Moses Goddard.

Empresas	Cargo	Fin
CytoSolv, Inc. CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology CytoSolv, Inc. develops proprietary technology to address wound healing. Its technology involves a mixture of wound-healing factors derived from porcine choroid plexus (CP), a key component of the blood brain barrier, which naturally secretes a variety of proteins into the cerebrospinal fluid responsible for growth, differentiation, nurturing and maintenance of the healing function. The company was founded by Moses Goddard and Christopher D. Thanos in 2009 and is headquartered in Providence, RI.	Fundador	-

Ver el detalle de la experiencia de Moses Goddard.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Moses Goddard.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
CytoSolv, Inc. CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology CytoSolv, Inc. develops proprietary technology to address wound healing. Its technology involves a mixture of wound-healing factors derived from porcine choroid plexus (CP), a key component of the blood brain barrier, which naturally secretes a variety of proteins into the cerebrospinal fluid responsible for growth, differentiation, nurturing and maintenance of the healing function. The company was founded by Moses Goddard and Christopher D. Thanos in 2009 and is headquartered in Providence, RI.	Health Technology
Semma Therapeutics, Inc. Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.	Health Technology